期刊文献+

晚发型糖原贮积病Ⅱ型1例患者的临床和病理及其家系GAA基因分析

Clinical and Pathological Characteristics and Genetic Analysis of A Patient with Late Onset Pompe Disease
原文传递
导出
摘要 目的研究1例晚发型糖原贮积病Ⅱ型(GSDⅡ)患者的临床、病理和遗传特征。方法回顾性分析1例晚发型GSDⅡ患者的临床资料和骨骼肌病理特征,同时取得患者和家属知情同意后对其家系进行遗传咨询,提取外周血白细胞基因组DNA,应用聚合酶链反应(PCR)扩增酸性-α-葡萄糖苷酶(GAA)的基因编码区,直接测序分析GAA基因突变情况。结果 1患者男性21岁,临床表现为呼吸肌、四肢近端肌无力。肌电图提示肌源性损害。三角肌病理和免疫组化染色提示肌源性损害,酸性磷酸酶染色(+)。血GAA活性明显低于正常,符合晚发型GSDⅡ诊断。2家系GAA基因分析提示,患者及其父亲和2位姑姑(父亲的妹妹)均携带一个未见报道的GAA基因新突变:位于第8号外显子的缺失突变(p.Met439del);患者及其母亲、外祖母均携带一个已报道的GAA基因16号外显子错义突变(p.Trp746Cys);该家系中发现一些非致病性杂合突变。结论在晚发型GSDⅡ家系中发现一个新的GAA基因第8号外显子缺失突变p.Met439del。先证者因存在双杂合突变导致GAA活性下降并出现晚发型GSDⅡ的临床和病理改变。 Aim To summarize the clinical, pathological and genetic characteristics of a pedigree with late onset Pompe disease (LOPD). Methods Clinical and pathological data of the proband of LOPD were collected and GAA gene was analyzed using direct sequence of PCR-ampliifed genomic DNA. GAA gene analysis was performed in the pedigrees. Results The proband was a 21 year-old man presented with weakness in extremities and a sudden respiratory failure typeⅡ, along with severely decreased serum GAA enzyme activity, all of which were typical manifestations of LOPD. A new deletion mutation of p.Met439del in exon 8, which had not been reported elsewhere before was detected in one chromosome of the proband, his father and two aunts. The proband also had a known pathogenic missense mutation of p.Trp746Cys in the other chromosome. This missense mutation also existed in his mother and grandmother. Other known low pathogenic GAA gene mutations were found in the pedigree. Conclusion The compound heterozygosity with the deletion mutation of p.Met439del and known pathogenic missense mutation of p.Trp746Cys caused the clinical presentation of LOPD in the proband. A new deletion mutation of p.Met439del in exon 8 was postulated a pathogenic GAA gene mutation in LOPD.
出处 《中国临床神经科学》 2014年第6期646-652,共7页 Chinese Journal of Clinical Neurosciences
关键词 糖原贮积病Ⅱ型 α葡糖苷酶类 基因 突变 谱系 glycogen storage disease typeⅡ/Pompe disease alpha-glucosidases gene mutation pedigree
  • 相关文献

参考文献15

  • 1Martiniuk F, Chen A, Mack A, et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease[J]. Am J Med Genet,1998,79:69-72.
  • 2Ausems MG, Verbiest J, Hermans MP, et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling [J]. Eur J Hum Genet, 1999,7:713-716.
  • 3Lin CY, Hwang B, Hsiao KJ, et al. Pompe's disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity[J]. J Inherit Metab Dis, 1987,10:11 - 17.
  • 4中华医学会儿科学分会内分泌遗传代谢学组,中华医学会儿科学分会神经学组,中华医学会神经病学分会肌电图与临床神经生理学组,等.糖原贮积病II型诊断及治疗专家共识[J].中华医学杂志,2013,93:1370—1373.
  • 5曾敏慧,邱文娟,顾学范,王瑜,周建德,叶军,韩连书,张惠文.一个糖原累积病Ⅱ型家系的酸性-α-葡萄糖苷酶及其产前基因诊断[J].中华医学遗传学杂志,2011,28(3):261-265. 被引量:10
  • 6岳冬曰,朱雯华,奚剑英,林洁,罗苏珊,陆珺,赵重波,卢家红.晚发型糖原累积病Ⅱ型的临床和病理研究[J].中国临床神经科学,2012,20(4):367-371. 被引量:8
  • 7Raben N,Nichols RC, Martiniuk F, et al. A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II)[J]. Hum Mol Genet, 1996,5:995-1000.
  • 8Hermans MM, van Leenen D, Kroos MA, et al. Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II[J]. Hum Mutat,2004,23:47-56.
  • 9Femandez-Hojas R, Huie ML, Navarro C, et al. Identification of six novel mutations in the acid alpha-glucosidase gene in three Spanish patients with infantile onset glycogen storage disease type II (Pompe disease)[J]. Neuromuscul Disord,2002,12:159-166.
  • 10Kroos MA, Kirschner J, Gellerich FN, et al. A case of childhood Pompe disease demonstrating phenotypic variability of p.Asp645Asn[J]. Neuromuscul Disord,2004,14:371-374.

二级参考文献23

  • 1Kostera-Pruszezyk A, Opuehlik A, Lugowska A, et al. Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome. Neuromuscul Disord, 2006, 16:282- 285.
  • 2Labrousse P, Chien YH, Pomponio RJ, et al. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Mol Genet Metab, 2010, 99; 379-383.
  • 3Huie ML, Chen AS, Tsujino S, et al. Aberrant splicing in adult onset glycogen storage disease type Ⅱ (GSD Ⅱ ) : molecular identification of an IVS1 ( -13T→G) mutation in a majority of patients and a novel IVS10 (+1GT→CT) mutation. Hum Mol Genet, 1994, 3: 2231-2236.
  • 4Becker JA, Vlaeh J, Raben N, et al. The African origin of the common mutation in African American patients with glycogen storage disease type Ⅱ. Am J Hum Genet, 1998, 62:991 -994.
  • 5Tsujino S, Huie M, Kanazawa N, et al. Frequent mutations in Japanese patients with acid maltase deficiency. Neuromuscul Disord, 2000, 10: 599-603.
  • 6Wan L, Lee CC, Hsu CM, et al. Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type Ⅱ. J Neurol, 2008, 255: 831-838.
  • 7Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr, 2004, 144:S35 -43.
  • 8McCready ME, Carson NL, Chakraborty P, et al. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type Ⅱ. Mol Genet Metab, 2007, 92: 325-335.
  • 9Martiniuk F, Chen A, Mack A, et al. Carrier frequency for glycogen storage disease type Ⅱ in New York and estimates of affected individuals born with the disease. Am J Med Genet, 1998, 79: 69-72.
  • 10Chien YH, Chiang SC, Zhang XK, et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics, 2008, 122: 39-45.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部